CORT — Corcept Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Corcept Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	441	224	432	368	385
Net Total Accounts Receivable
Net Total Receivables	26.2	27.6	31.1	41.1	54
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	479	266	499	459	472
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.18	1.52	1.78	0.315	8.01
Long Term Investments
Other Long Term Assets
Total Assets	572	424	583	622	841
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	47.5	47.5	72.5	105	141
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	48.4	48	81.6	115	161
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	523	376	502	507	680
Total Liabilities & Shareholders' Equity	572	424	583	622	841
Total Common Shares Outstanding